LS
SGMO

Lupo Securities’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Lupo Securities’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$18K Buy
38
+2
+6% +$16 0.14% 57
2015
Q2 		$6K Sell
36
-2
-5% -$26 0.02% 71
2015
Q1 		$8K Buy
38
+21
+124% +$325 0.01% 312
2014
Q4 		$2.93K Buy
+17
New +$206 ﹤0.01% 442

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Lupo Securities's SGMO Position: Q3 2015 in Review

Lupo Securities increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 97% in Q3 2015, buying an estimated $39.2K and bringing the position to 9,650 shares worth $54K. The position accounts for 0.41% of the portfolio, ranked #31.

Lupo Securities first reported a position in SGMO in Q4 2014 and has held it in 4 quarters since. 141 funds tracked by Wall St. Rank hold SGMO as of Q3 2015.

  • Lupo Securities held 9,650 shares of SANGAMO THERAPEUTICS INC worth $54K as of Q3 2015.
  • Lupo Securities bought 4,750 SANGAMO THERAPEUTICS INC shares in Q3 2015, an estimated $39.2K.
  • SANGAMO THERAPEUTICS INC made up 0.41% of Lupo Securities's portfolio in Q3 2015, its #31 holding.
  • Lupo Securities first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and has held it in 4 quarters since.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.